Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma

Wenhui Ouyang, Jie Wang, Jie Chen, Zemin Fang, Ting Wei, Jiazi Qian, Shanying Gui

Open source

DOI
10.1016/j.trsl.2026.09.009
Published
2026-11
Container
Translational Research
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.trsl.2026.09.009,
  title = {Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma},
  author = {Wenhui Ouyang and Jie Wang and Jie Chen and Zemin Fang and Ting Wei and Jiazi Qian and Shanying Gui},
  year = {2026},
  journal = {Translational Research},
  doi = {10.1016/j.trsl.2026.09.009},
  url = {https://doi.org/10.1016/j.trsl.2026.09.009}
}

RIS

TY  - JOUR
TI  - Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma
AU  - Wenhui Ouyang
AU  - Jie Wang
AU  - Jie Chen
AU  - Zemin Fang
AU  - Ting Wei
AU  - Jiazi Qian
AU  - Shanying Gui
PY  - 2026
JO  - Translational Research
DO  - 10.1016/j.trsl.2026.09.009
UR  - https://doi.org/10.1016/j.trsl.2026.09.009
ER  - 

APA

Ouyang, W., Wang, J., Chen, J., Fang, Z., Wei, T., Qian, J., & Gui, S. (2026). Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma. Translational Research. https://doi.org/10.1016/j.trsl.2026.09.009

Source records